home / stock / ogen / ogen quote
Last: | $2.33 |
---|---|
Change Percent: | 2.44% |
Open: | $1.6 |
Close: | $2.33 |
High: | $2.4 |
Low: | $1.6 |
Volume: | 521,437 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.33 | $1.6 | $2.33 | $2.4 | $1.6 | 521,437 | 05-17-2024 |
$1.64 | $1.66 | $1.64 | $1.82 | $1.58 | 129,674 | 05-16-2024 |
$1.638 | $1.7 | $1.638 | $1.7398 | $1.5001 | 72,436 | 05-15-2024 |
$1.65 | $1.55 | $1.65 | $1.71 | $1.5 | 82,443 | 05-14-2024 |
$1.5 | $1.86 | $1.5 | $2.23 | $1.405 | 332,139 | 05-13-2024 |
$1.84 | $1.47 | $1.84 | $1.89 | $1.4019 | 440,842 | 05-10-2024 |
$1.38 | $1.24 | $1.38 | $1.4 | $1.1751 | 113,324 | 05-09-2024 |
$1.21 | $1.32 | $1.21 | $1.39 | $1.2 | 88,480 | 05-08-2024 |
$1.34 | $1.15 | $1.34 | $1.55 | $1.13 | 586,112 | 05-07-2024 |
$1.08 | $1.1 | $1.08 | $1.1799 | $1.0601 | 36,920 | 05-06-2024 |
$1.07 | $1.06 | $1.07 | $1.07 | $1.0327 | 15,688 | 05-03-2024 |
$1.0501 | $1.02 | $1.0501 | $1.07 | $1.02 | 11,185 | 05-02-2024 |
$1.02 | $1.01 | $1.02 | $1.04 | $1.01 | 9,040 | 05-01-2024 |
$1.035 | $1.05 | $1.035 | $1.06 | $1.02 | 8,221 | 04-30-2024 |
$1.01 | $1.07 | $1.01 | $1.07 | $1 | 35,440 | 04-29-2024 |
$1.03 | $1.07 | $1.03 | $1.08 | $1.01 | 43,816 | 04-26-2024 |
$1.06 | $1.1 | $1.06 | $1.15 | $1.049 | 61,782 | 04-25-2024 |
$1.09 | $1.11 | $1.09 | $1.11 | $1.05 | 9,186 | 04-24-2024 |
$1.09 | $1.07 | $1.09 | $1.09 | $1.03 | 18,832 | 04-23-2024 |
$1.06 | $1.1 | $1.06 | $1.13 | $1.04 | 15,021 | 04-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
SARASOTA, Fla., May 17, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneering pharmaceutical company specializing in intranasal treatments for neurological disorders, today announced that the company will host a webinar panel on Neurotrauma Medicine Monday, May 20, 2024, at...
SARASOTA, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneering pharmaceutical company specializing in intranasal treatments for neurological disorders, today announced an update on the company and its drug development program. Oragenics is designing an upcomi...
A look at the top 10 most actives in the United States Novavax Inc. (NVAX) rose 98.7% to $8.88 on volume of 168,692,127 shares AEye Inc. (LIDR) rose 115.0% to $2.58 on volume of 156,236,079 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) fell 17.3% to $0.7609 on volume of 123,678,040 s...